Baxter International Inc BAX:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
77.75quote price arrow up+0.06 (+0.08%)
Volume
121,892
Close
77.69quote price arrow down-0.96 (-1.22%)
Volume
4,753,476
52 week range
69.10 - 95.19

...

Loading . . .

KEY STATS

  • Open78.81
  • Day High78.94
  • Day Low76.80
  • Prev Close78.65
  • 52 Week High95.19
  • 52 Week High Date04/20/20
  • 52 Week Low69.10
  • 52 Week Low Date03/16/20
  • Market Cap39.241B
  • Shares Out505.10M
  • 10 Day Average Volume2.79M
  • Dividend0.98
  • Dividend Yield1.26%
  • Beta0.66
  • 1 Year % Change-7.81

RATIOS/PROFITABILITY

  • EPS (TTM)2.13
  • P/E (TTM)36.45
  • Fwd P/E (NTM)25.02
  • EBITDA (MRQ)2.78B
  • ROE (MRQ)13.30%
  • Revenue (MRQ)11.673B
  • Gross Margin (MRQ)39.71%
  • Net Margin (MRQ)9.51%
  • Debt To Equity (MRQ)71.26%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date02/25/2021
  • Div Amount0.245
  • Split Date-
  • Split Factor-

Latest Baxter International Inc News

QUOTE FINDER

Profile

MORE
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery...
Jose Almeida
Chairman
James Saccaro
Chief Financial Officer
Address
1 Baxter Pkwy
Deerfield, IL
60015-4625
United States